Aquaporin-4-Positive Triple-Negative Breast Cancer Presenting with Paraneoplastic Neuromyelitis Optica Spectrum Disorder

• Published in: Biomedicine hub Vol. 7; no. 1; pp. 11 - 16
• Main Authors: Carrillo, Pilar, Gorría, Teresa, Santana, Daniel, Sepulveda, Maria, Aldecoa, Iban, Gonzalez-Farré, Blanca, Sanfeliu, Esther, Mension, Eduard, Cebrecos, Isaac, Martínez-Saez, Olga, Alonso, Imma, Saiz, Albert
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 2022; Karger Publishers
• Subjects: Aquaporin 4; Aquaporins; Autoimmune diseases; Biopsy; Breast cancer; Cancer therapies; Carboplatin; Case reports; Central nervous system; Cerebrospinal fluid; Chemotherapy; Corticosteroids; Immunoglobulin G; Immunosuppressive agents; Immunotherapy; Lymphatic system; Magnetic resonance imaging; Mammography; Mastectomy; Metastases; Metastasis; Monoclonal antibodies; Myelitis; Nervous system; Neuromyelitis; neuromyelitis optica; Novel Insights from Clinical Practice; Optic nerve; Ostomy; Paclitaxel; Paraneoplastic syndrome; Patients; Respiratory failure; Rituximab; Spinal cord; Targeted cancer therapy; triple-negative breast cancer; Tumors; Neuromyelitis optica; Paraneoplastic syndrome; Breast cancer; Aquaporin-4; Triple-negative breast cancer
• ISSN: 2296-6870; 2296-6862; 2296-6870
• DOI: 10.1159/000521578

Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory central nervous system disorder that preferentially affects the optic nerve and the spinal cord. Although NMOSD is more commonly an idiopathic autoimmune condition associated with antibodies against aquaporin-4 (AQP4)-IgG, the disease may also occur as a paraneoplastic syndrome in rare instances. In these cases, the expression of AQP4 by the tumor is likely the trigger of the autoimmune response. Case Presentation: We describe the case of a 32-year-old woman who presented with progressive tetraparesis, cranial involvement, respiratory failure, and spinal cord MRI compatible with longitudinally extensive transverse myelitis, few days after being diagnosed with a T3N1M0 triple-negative right breast cancer. Due to the history of concurrent breast cancer and after ruling out metastatic spinal cord involvement, the possibility of a paraneoplastic origin was raised. AQP4-IgG were found in the serum and CSF by cell-based assay, confirming the diagnosis of NMOSD. The patient was treated with corticosteroids, plasma exchange, and rituximab. Concomitantly, breast cancer therapy was started with an adapted neoadjuvant chemotherapy scheme based on carboplatin and paclitaxel. An initial slight improvement slowed down; so, a right mastectomy with lymphadenectomy was performed. Expression of AQP4 was demonstrated in the tumor. The patient presented a significant neurological improvement after combined treatment regaining muscular balance and strength in upper and lower extremities. Conclusion: NMOSD may have a paraneoplastic origin associated with breast cancer and the importance of its early detection since the combination of tumoral and immunosuppressive therapy may improve the patient’s prognosis.